Immunogenicity, Safety and Reactogenicity of a Booster Dose of the 10-Valent Pneumococcal Nontypeable H. influenzae Protein D Conjugate Vaccine Coadministered With DTPa-IPV-Hib in Dutch Children-Reference-Cited by-同舟云学术

Immunogenicity, Safety and Reactogenicity of a Booster Dose of the 10-Valent Pneumococcal Nontypeable H. influenzae Protein D Conjugate Vaccine Coadministered With DTPa-IPV-Hib in Dutch Children

Published:2016-07 Issue:7 Volume:35 Page:e206-e219
ISSN:0891-3668
Container-title:Pediatric Infectious Disease Journal
language:en
Short-container-title:

Author:

van den Bergh Menno R.,Spijkerman Judith,François Nancy,Swinnen Kristien,Borys Dorota,Schuerman Lode,Veenhoven Reinier H.,Sanders Elisabeth A. M.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Microbiology (medical),Pediatrics, Perinatology, and Child Health

Reference38 articles.

1. Comparative effects of carrier proteins on vaccine-induced immune response.;Knuf;Vaccine,2011

2. Glycoconjugate vaccines and immune interference: a review.;Dagan;Vaccine,2010

3. The influence of carrier protein on the immunogenicity of simultaneously administered conjugate vaccines in infants.;Pöllabauer;Vaccine,2009

4. 10-valent pneumococcal nontypeable Haemophilus influenzae PD conjugate vaccine: Synflorix.;Prymula;Expert Rev Vaccines,2009

5. Immunogenicity, safety, and reactogenicity of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine and DTPa-IPV-Hib when coadministered as a 3-dose primary vaccination schedule in The Netherlands: a randomized controlled trial.;van den Bergh;Pediatr Infect Dis J,2011

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis;Health Technology Assessment;2024-07

2. Immunogenicity and seroefficacy of 10-valent and 13-valent pneumococcal conjugate vaccines: a systematic review and network meta-analysis of individual participant data;eClinicalMedicine;2023-07

3. Immunogenicity and seroefficacy of pneumococcal conjugate vaccines – a systematic review and network meta-analysis;2023-01-14

4. Immunogenicity, otitis media, hearing impairment, and nasopharyngeal carriage 6-months after 13-valent or ten-valent booster pneumococcal conjugate vaccines, stratified by mixed priming schedules: PREVIX_COMBO and PREVIX_BOOST randomised controlled trials;The Lancet Infectious Diseases;2022-09

5. Brief communication: immunogenicity of measles vaccine when co-administered with 10-valent pneumococcal conjugate vaccine;npj Vaccines;2020-08-18